Assessing Agilent Technologies: Insights From 6 Financial Analysts
Portfolio Pulse from Benzinga Insights
In the last three months, 6 analysts have provided diverse ratings on Agilent Technologies (NYSE:A), with a shift towards more cautious views in the recent 30 days. The average 12-month price target for Agilent has increased to $136.67, up 8.9% from the previous $125.50. Analyst actions include both upgrades and downgrades, reflecting varied expectations for the company's performance. Agilent, a life sciences and diagnostics firm, shows strong financial health with a high net margin and ROE, despite a recent revenue decline of -8.71%.
February 28, 2024 | 6:00 pm
News sentiment analysis
Sort by:
Descending
POSITIVE IMPACT
Agilent Technologies has received mixed ratings from analysts, with a recent shift towards more cautious views. The average 12-month price target has increased to $136.67, indicating a positive outlook despite a recent revenue decline.
The mixed analyst ratings with a recent cautious shift reflect uncertainty and varied expectations for Agilent's performance. However, the increase in the average price target suggests a generally positive outlook. The company's strong financial health, indicated by high net margin and ROE, despite a recent revenue decline, supports a potentially positive short-term impact on the stock price.
CONFIDENCE 85
IMPORTANCE 90
RELEVANCE 100